Ampulla of Vater carcinoma: advancement in the relationships between histological subtypes, molecular features, and clinical outcomes

H Liang, Y Zhu, Y Wu - Frontiers in Oncology, 2023 - frontiersin.org
The incidence of ampulla of Vater carcinoma, a type of periampullary cancer, has been
increasing at an annual percentage rate of 0.9%. However, patients with ampulla of Vater …

Ampullary Adenocarcinoma: A Review of the Mutational Landscape and Implications for Treatment

V Tsagkalidis, RC Langan, BL Ecker - Cancers, 2023 - mdpi.com
Simple Summary Ampullary tumors are rare malignancies of the upper gastrointestinal tract.
Histologic, immunohistochemical and, most recently, genomic biomarkers have been used …

A novel approach to quantify heterogeneity of intrahepatic cholangiocarcinoma: the hidden-genome classifier

Y Song, T Boerner, E Drill, P Shin, S Kumar… - Clinical Cancer …, 2024 - aacrjournals.org
Purpose: Intrahepatic cholangiocarcinoma (IHC) is a heterogeneous tumor. The hidden-
genome classifier, a supervised machine learning–based algorithm, was used to quantify …

Genome-derived ampullary adenocarcinoma classifier and postresection prognostication

BL Ecker, K Seier, AM Eckhoff, GN Tortorello… - JAMA …, 2024 - jamanetwork.com
Importance Ampullary adenocarcinoma (AA) is characterized by clinical and genomic
heterogeneity. A previously developed genomic classifier defined biologically distinct …

[HTML][HTML] Machine learning models for predicting survival in patients with ampullary adenocarcinoma

T Huang, L Huang, R Yang, S Li, N He, A Feng… - Asia-Pacific Journal of …, 2022 - Elsevier
Objective The aim of this study was to predict the long-term survival probability of patients
with ampullary adenocarcinoma (AAC), which would provide a theoretical basis for the long …

Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation

MP Linscott, H Markus, M Sennett, C Abendroth… - Biomedicines, 2023 - mdpi.com
Ampullary adenocarcinoma is a rare malignancy that lacks standard systemic treatment. We
describe a case of recurrent metastatic ampullary adenocarcinoma of the pancreaticobiliary …

Ampullary adenocarcinoma, version 1.2023, NCCN clinical practice guidelines in oncology

EG Chiorean, M Del Chiaro, MA Tempero… - Journal of the National …, 2023 - jnccn.org
Ampullary cancers refer to tumors originating from the ampulla of Vater (the ampulla, the
intraduodenal portion of the bile duct, and the intraduodenal portion of the pancreatic duct) …

Clinicopathologic features and genetic alterations in mixed-type ampullary carcinoma

J Kawata, Y Koga, S Noguchi, Y Shimada, Y Yamada… - Modern Pathology, 2023 - Elsevier
Mixed-type ampullary carcinoma is a subtype that combines intestinal-type (I-type) and
pancreatobiliary-type (PB-type) lesions, but few studies have examined its clinicopathologic …

[HTML][HTML] Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer

JZ Zhang, ZW Zhang, XY Guo, DS Zhu… - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
BACKGROUND Ampullary cancer is a relatively rare malignant tumor in the digestive
system. Its incidence has increased in recent years. As for now, its biological characteristics …

Topical hidden genome: discovering latent cancer mutational topics using a Bayesian multilevel context-learning approach

S Chakraborty, Z Guan, CB Begg, R Shen - Biometrics, 2024 - academic.oup.com
Inferring the cancer-type specificities of ultra-rare, genome-wide somatic mutations is an
open problem. Traditional statistical methods cannot handle such data due to their ultra-high …